β2-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis

被引:104
作者
Du, XJ [1 ]
Autelitano, DJ [1 ]
Dilley, RJ [1 ]
Wang, BH [1 ]
Dart, AM [1 ]
Woodcock, EA [1 ]
机构
[1] Baker Med Res Inst, Melbourne, Vic 8008, Australia
关键词
genetics; receptors; adrenergic; beta; hypertrophy; heart failure; pressure;
D O I
10.1161/01.CIR.101.1.71
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-beta-Adrenergic signaling is downregulated in the failing heart, and the significance of such change remains unclear. Methods and Results-To address the role of P-adrenergic dysfunction in heart failure (HF), aortic stenosis (AS) was induced in wild-type (WT) and transgenic (TG) mice with cardiac targeted overexpression of beta(2)-adrenergic receptors (ARs), and animals were studied 9 weeks later. The extents of increase in systolic arterial pressure (P<0.01 versus controls), left ventricular (LV) hypertrophy (TG, 94+/-6 to 175+/-7 mg; WT, 110+/-6 to 168+/-10 mg; both P<0.01), and expression of ANP mRNA were similar between TG and WT mice with AS. TG mice had higher incidences of premature death and critical illness due to heart failure (75% versus 23%), pleural effusion (81% versus 45%), and left atrial thrombosis (81% versus 36%, all P<0.05). A more extensive focal fibrosis was found in the hypertrophied LV of TG mice (P<0.05). These findings indicate a more severe LV dysfunction in TG mice. In sham-operated mice, LV dP/dt(max) and heart rate were markedly higher in TG than WT mice (both P<0.01). dP/dt(max) was lower in both AS groups than in sham-operated controls, and this tended to be more pronounced in TG than WT mice (-32+/-5% versus -16+/-6%, P=0.059), although dP/dt(max) remained higher in TG than WT groups (P<0.05). Conclusions-Elevated cardiac beta-adrenergic activity by beta(2)-AR overexpression leads to functional deterioration after pressure overload.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 34 条
[1]   Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer [J].
Akhter, SA ;
Skaer, CA ;
Kypson, AP ;
McDonald, PH ;
Peppel, KC ;
Glower, DD ;
Lefkowitz, RJ ;
Koch, WJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) :12100-12105
[2]   MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure [J].
Arber, S ;
Hunter, JJ ;
Ross, J ;
Hongo, M ;
Sansig, G ;
Borg, J ;
Perriard, JC ;
Chien, KR ;
Caroni, P .
CELL, 1997, 88 (03) :393-403
[3]   Selective activation of α1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of α1-adrenergic receptor subtype mRNAs [J].
Autelitano, DJ ;
Woodcock, EA .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (08) :1515-1523
[4]   ISOPROTERENOL-INDUCED MYOCARDIAL FIBROSIS IN RELATION TO MYOCYTE NECROSIS [J].
BENJAMIN, IJ ;
JALIL, JE ;
TAN, LB ;
CHO, K ;
WEBER, KT ;
CLARK, WA .
CIRCULATION RESEARCH, 1989, 65 (03) :657-670
[5]  
BISHOPRIC NH, 1992, J BIOL CHEM, V267, P20932
[6]   Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy [J].
Bogoyevitch, MA ;
Andersson, MB ;
GillespieBrown, J ;
Clerk, A ;
Glennon, PE ;
Fuller, SJ ;
Sugden, PH .
BIOCHEMICAL JOURNAL, 1996, 314 :115-121
[7]   PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR [J].
BOND, RA ;
LEFF, P ;
JOHNSON, TD ;
MILANO, CA ;
ROCKMAN, HA ;
MCMINN, TR ;
APPARSUNDARAM, S ;
HYEK, MF ;
KENAKIN, TP ;
ALLEN, LF ;
LEFKOWITZ, RJ .
NATURE, 1995, 374 (6519) :272-276
[8]   Mechanism of action of beta-blocking agents in heart failure [J].
Bristow, MR .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 (11A) :L26-L40
[9]   REDUCED BETA(1) RECEPTOR MESSENGER-RNA ABUNDANCE IN THE FAILING HUMAN HEART [J].
BRISTOW, MR ;
MINOBE, WA ;
RAYNOLDS, MV ;
PORT, JD ;
RASMUSSEN, R ;
RAY, PE ;
FELDMAN, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2737-2745
[10]   Medical therapy can improve the biological properties of the chronically failing heart - A new era in the treatment of heart failure [J].
Eichhorn, EJ ;
Bristow, MR .
CIRCULATION, 1996, 94 (09) :2285-2296